Moreover, Witkiewicz AK et al. reported that p16INK4a was elevated in ductal carcinoma in situ and stoma of breast cancer, and that elevated p16INK4a expression was closely related to disease recurrence [44]. This evidence concerns the gene CDKN2A and breast carcinoma.